Search
for
Sort by
Research 511–540 of 1000+
- Safety of dermatologic medications in pregnancy and lactation
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- A new path in defining light parameters for hair growth: Discovery and modulation of photoreceptors in human hair follicle
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng
- Telogen effluvium
- Dermatology of androgen-related disorders
- Management of congenital ichthyoses: European guidelines of care, part two
- Clinical evaluation of alopecias using a handheld dermatoscope
- Menstrual Irregularity in Women with Acromegaly
- Primary cicatricial alopecia
- The Spectrum of Skin Disease Among Indian Children
- Dermatoscopic features of central centrifugal cicatricial alopecia
- The role of lymphocytes in the development and treatment of alopecia areata
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Apoptosis and cutaneous biology
- Graft-versus-host disease
- Regulatory roles of androgens in cutaneous wound healing
- Female Pattern Hair Loss
- Strategies to enhance epithelial–mesenchymal interactions for human hair follicle bioengineering
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Advances in the management of alopecia areata
- Design of a biofluid-absorbing bioactive sandwich-structured Zn–Si bioceramic composite wound dressing for hair follicle regeneration and skin burn wound healing
- Dermal White Adipose Tissue: A Newly Recognized Layer of Skin Innate Defense
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- TOXIC EPIDERMAL NECROLYSIS